Document is current

Article History

Received: 7 July 2019

Accepted: 22 January 2020

First Online: 21 February 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: Gustavo Gomes Resende received lecture fees from Abbvie, Janssen, Novartis, Pfizer, and UCB; advisory board from Abbvie, Janssen, and Novartis; Research support from Brazilian Society of Rheumatology, FAPEMIG and UCB; clinical research payments from Abbvie and Pfizer; sponsorship for scientific events from Abbvie, Janssen, Lilly, Novartis, Pfizer, and UCB.Eduardo de Souza Meirelles received payments as a speaker from Novartis, Abbvie, Abbott and Marjan; research grants from Novartis and Pfizer; support for conferences and courses from Aché, Pfizer, Novartis, Janssen, Abbvie, Roche, and Lilly; Advisory board fee from Novartis and Marjan.Cláudia Diniz Lopes Marques received lecture fees from Abbvie, Janssen, Pfizer and Novartis; advisory board from Novartis and Abbvie; sponsorship for events from Abbvie, Janssen, Pfizer, Novartis, and Lilly.Adriano Chiereghin received honoraria as a speaker from Janssen, Novartis, UCB, and Pfizer; support to courses and congresses from Abbvie, Janssen, Novartis, UCB, and Pfizer; advisory board from Novartis and Janssen.Andre Marun Lyrio received payments from Speaker of Janssen and UCB; support to courses/congresses from Janssen, Abbvie, Pfizer, UBC, Novartis, and Lily.Antônio Carlos Ximenes received payments for participation in clinical research from Abbvvie, Pfizer, Roche, BMS, and Amgen; on scientific board of Pfizer, and Abbivie; as a lecturer from AbbVie, Pfizer, and Abbott.Carla Gonçalves Saad has no conflicts of interest.Célio Roberto Gonçalves has no conflicts of interest.Charles Lubianca Kohen received financial support for advisory board participation from Novartis; speaker fee from Janssen, Abbvie, Novartis, Pfizer, UCB; support to events from Janssen, Abbvie, Roche, Astra-Zeneca, Novartis.Cláudia Goldenstein Schainberg has participated in the pharmaceutical advisory board of AbbVie, Janssen, Lilly, Novartis, and Pfizer; is a speaker invited by AbbVie, Janssen, Lilly, Novartis, Pfizer; has no stock of these pharmaceutical industries.Cristiano Barbosa Campanholo received financial support for advisory board participation from Janssen, Abbvie, Bristol, Lilly, Novartis, Pfizer, UCB; speaker fee from Janssen, Abbvie, Lilly, Novartis, and Pfizer, UCB; support to events from Janssen, Abbvie, Bristol, Novartis, and Pfizer.Júlio Silvio de Sousa Bueno Filho has no conflicts of interest.Lenise Brandao Pieruccetti has no conflicts of interest.Mauro Waldemar Keiserman received financial support for lectures, advisory bord and clinical research from Abbvie, Actelion, Biogen, Bristol, Celltrion, Lilly, Human Genome Sceiences, Janssen, Pfizer, Novartis, Roche, Sanofi, and UCB.Michel Alexandre Yazbek received financial support from Abbvie, UCB, Novartis and Lilly.Penelope Esther Palominos has no conflicts of interest.Rafaela Silva Guimarães Goncalves received fees for lectures from Janssen, Novertis, Abbvie, Apsen, Bristol, and Pfizer; advisory board from Janssen.Ricardo da Cruz Lage received speakers fee from Abbvie and Novartis; support to scientific events from Janssen, Novartis, Pfizer and Abbvie; clinical research payments from Abbvie.Rodrigo Luppino Assad received fees for lectures and advisory board from Abbvie, Novartis, Janssen, UCB, Lilly, and Bristol; research support from Abbvie and UCB.Rubens Bonfiglioli received financial support for clinical research from Roche, Pfizer, Amgen, and Novartis; for scientific advisory from Lilly, Abbvie, Roche, and UCB; for support to events from Roche, Pfizer, Abbvie and Novartis; for symposia and sponsored meetings from Roche, Pfizer, and Janssen.Sônia Maria Alvarenga Anti received financial support from Abbvie, Jansen, Novartis, Lilly, and UCB.Sueli Coelho da Silva Carneiro received honorary speaker from Abbvie, Janssen, Lilly, Novartis and Pfizer; support to research from CNPq and FAPERJ; support for congresses from Abbvie, Janssen, Novartis, Pfizer, CNPq and FAPERJ; advisory board from Janssen, Lilly, and Novartis.Thauana Luíza Oliveira received lecturer fees from Abbvie, Novartis and Janssen; support to congresses from Abbvie and Janssen.Valderílio Feijó Azevedo is GRAPPA member; Medical diretor of Edumed Biotech; received for clinical research from Pfizer, Roche, Janssen, Bristol, Abbvie, Medimmune, Boehringer, GSK, USB, Sanofi, Takeda, Bird Rock Bio, and NovoNordisk; financial support to events and lectures from Pfizer, Hospira, Roche, MSD, BMS, Merck Senoro, Janssen, Novertis, Celltrion, UCB, and AztraZeneca.Washington Alves Bianchi has no conflicts of interest.Wanderley Marques Bernardo has no conflicts of interest.Marcelo de Medeiros Pinheiro received financial support for advisory board from Novartis and Janssen; by lectures from Novartis, Janssen, Abbvie.Percival Degrava Sampaio-Barros received for participation in lectures, boards or scientific events from laboratories Abbvie, Janssen, Novartis, Pfizer and UCB.